Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
Critical Reviews in Oncology/Hematology|October 20, 2022
A systematic review of contemporary phase I trials in patients with lymphomaG Griguolo, M F Zorzi, M C Pirosa, et al.
International Journal of Legal Medicine|October 1, 2014
Ground truth data generation for skull-face overlayO Ibáñez, F Cavalli, B R Campomanes-Álvarez, et al.
Bone Marrow Transplantation|January 1, 1997
High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern SwitzerlandS Regazzoni, G Marini, A Grob, et al.
Cancer Research|May 1, 1986
Pharmacokinetics of etoposide in patients with abnormal renal and hepatic functionM D'Incalci, C Rossi, M Zucchetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemiaL Tschopp, V E von Fliedner, C Sauter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Low-dose oral etoposide in epithelial cancer of the ovaryM Marzola, M Zucchetti, N Colombo, et al.
Schweizerische Medizinische Wochenschrift|December 31, 1988
[Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences]K W Brunner, F Harder, R Greiner, et al.
Cancer|November 1, 1981
Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group BF Cavalli, W F Jungi, N I Nissen, et al.
British Journal of Haematology|June 9, 2007
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni, F Berger, C Chassagne-Clement, et al.
Annals of Hematology|April 18, 2013
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trialF Hitz, N Fischer, Th Pabst, et al.
Pageof 29